Literature DB >> 23529290

Subclinical cardiovascular disease assessment in persons with diabetes.

Haider Javed Warraich1, Khurram Nasir.   

Abstract

Patients with diabetes mellitus are at particularly high risk for cardiovascular disease. Although global risk factor scoring systems, such as the Framingham Risk Score, are well established for screening asymptomatic adults, they are not as predictive in diabetics. Therefore, there has been considerable interest in new screening tests to establish cardiovascular risk in diabetics. Coronary artery calcium assessment, both baseline levels and progression, have been shown to be additive to risk factor scoring systems and are independently predictive of cardiovascular mortality in diabetics. Current American Heart Association/American College of Cardiology Foundation guidelines recommend coronary calcium scoring for asymptomatic diabetics. Myocardial perfusion studies are recommended for patients with a coronary calcium score >400 but the level of evidence is poor. The data for other screening tests is limited. Further research is required into assessing what would be an appropriate follow-up duration for serial coronary calcium scanning.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529290     DOI: 10.1007/s11886-013-0358-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  72 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors.

Authors:  Viktor Culić; Davor Eterović; Dinko Mirić; Nardi Silić
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

4.  Diabetes and progression of coronary calcium under the influence of statin therapy.

Authors:  Matthew J Budoff; Dale Yu; Khurram Nasir; Rajnish Mehrotra; Lynn Chen; Junichiro Takasu; Nisha Agrawal; Sandy T Liu; Roger S Blumenthal
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

5.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study.

Authors:  Raimund Erbel; Stefan Möhlenkamp; Susanne Moebus; Axel Schmermund; Nils Lehmann; Andreas Stang; Nico Dragano; Dietrich Grönemeyer; Rainer Seibel; Hagen Kälsch; Martina Bröcker-Preuss; Klaus Mann; Johannes Siegrist; Karl-Heinz Jöckel
Journal:  J Am Coll Cardiol       Date:  2010-10-19       Impact factor: 24.094

6.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

7.  Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hanyu Ni; Sean Coady; Wayne Rosamond; Aaron R Folsom; Lloyd Chambless; Stuart D Russell; Paul D Sorlie
Journal:  Am Heart J       Date:  2008-10-26       Impact factor: 4.749

8.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

9.  Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis.

Authors:  Shaista Malik; Matthew J Budoff; Ronit Katz; Roger S Blumenthal; Alain G Bertoni; Khurram Nasir; Moyses Szklo; R Graham Barr; Nathan D Wong
Journal:  Diabetes Care       Date:  2011-08-15       Impact factor: 19.112

10.  Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes.

Authors:  Kui-Kai Lau; Yuen-Kwun Wong; Yap-Hang Chan; Kai-Hang Yiu; Kay-Cheong Teo; Leonard Sheung-Wai Li; Shu-Leong Ho; Koon-Ho Chan; Chung-Wah Siu; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2012-08-18       Impact factor: 9.951

View more
  2 in total

1.  Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.

Authors:  Bernt Johan von Scholten; Henrik Reinhard; Tine Willum Hansen; Morten Lindhardt; Claus Leth Petersen; Niels Wiinberg; Peter Riis Hansen; Hans-Henrik Parving; Peter Karl Jacobsen; Peter Rossing
Journal:  Cardiovasc Diabetol       Date:  2015-05-21       Impact factor: 9.951

2.  Brazilian adult individuals with untreated isolated GH deficiency do not have accelerated subclinical atherosclerosis.

Authors:  Ursula M M Costa; Carla R P Oliveira; Roberto Salvatori; José A S Barreto-Filho; Viviane C Campos; Francielle T Oliveira; Ivina E S Rocha; Joselina L M Oliveira; Wersley A Silva; Manuel H Aguiar-Oliveira
Journal:  Endocr Connect       Date:  2016-01-25       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.